Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PAVmed (PAVM) Debt to Equity (2022 - 2025)

PAVmed (PAVM) has 4 years of Debt to Equity data on record, last reported at $0.21 in Q3 2025.

  • For Q3 2025, Debt to Equity changed N/A year-over-year to $0.21; the TTM value through Sep 2025 reached $0.21, changed N/A, while the annual FY2024 figure was -$11.66, 533.78% down from the prior year.
  • Debt to Equity reached $0.21 in Q3 2025 per PAVM's latest filing, down from $0.24 in the prior quarter.
  • Across five years, Debt to Equity topped out at $4.1 in Q1 2023 and bottomed at -$11.66 in Q4 2024.
  • Average Debt to Equity over 4 years is -$0.54, with a median of $0.19 recorded in 2025.
  • Peak YoY movement for Debt to Equity: plummeted 653.47% in 2024, then skyrocketed 110.23% in 2025.
  • A 4-year view of Debt to Equity shows it stood at $3.08 in 2022, then crashed by 159.8% to -$1.84 in 2023, then crashed by 533.78% to -$11.66 in 2024, then skyrocketed by 101.82% to $0.21 in 2025.
  • Per Business Quant database, its latest 3 readings for Debt to Equity were $0.21 in Q3 2025, $0.24 in Q2 2025, and $0.17 in Q1 2025.